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Considerable progress has been made over the past 30e40 years in the
development of quantitative imaging methods for assessing the skeleton
noninvasively and/or nondestructively, so that skeletal disorders, especially
osteoporosis, can be detected early, progression and response to therapy
monitored, and fracture risk determined. Clinicians and researchers can now
evaluate the peripheral, central, or entire skeleton as well as the
trabecular, cortical and endosteal envelopes with a high degree of accuracy
and precision, and they can reliably estimate bone strength and the
propensity to fracture. The purposes of this presentation are to review the
historical background and evolution of the series of International Bone
Density Workshops and their collective promotion, advancement and overall
impact on the development and application of the various methods for
quantitative bone imaging in preclinical and clinical research.
The numerousmethods for noninvasive assessment of the skeleton began their
evolution in the late 1960s and 70s’, with simple X-ray-based radiogrammetry,
high-resolution fine-detail radiography, radiographic absorptiometry, and
single-photon absorptiometry (SPA), all emerging as research tools, with
only the latter becoming a clinical tool available in North America, Europe and
Asia. Supporting and driving these methodological advances were the growing
interests in postmenopausal osteoporosis and in bone loss during space flight,
as evidenced by the first NIH, NASA, University and Industry sponsored bone
density workshops, and the initiation of the biennial series of International
Bone Density Workshops (IBDWs). During this early period the nascent
foundations were laid for what has evolved as our most eminent bone mineral
societies, namely, the ASBMR, ECTS, IBMS, and IOF.
The IBDWs (Table) have served as a focal point for research and innovation
centering on the development and application of non-invasive methods for
assessing skeletal status, bringing together in an international forum,
leading scientists, engineers and clinicians with broad interdisciplinary
perspectives and representing both academia and industry. Uniquely the
IBDWs have gathered those particularly interested in developing, advancing2214-031X/$36. Copyrightª 2014, TheAuthors. Published by Elsevier (Sin
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).and applying novel technologies in an informal environment encouraging
open discussions fostering a collegiality built on familiarity, understanding
and respect amongst the participants.
During the ‘80s and 90s’, the medical imaging technologies exploded with the
advent of ultrasound, computed tomography (CT) and a decade later, with
magnetic resonance imaging (MRI), each opening new perspectives varying
from applying non-ionizing-radiation based imaging technology to in vivo 3-
dimensional multi-planar sectioning of the body. Quantitative ultrasound
(QUS)was studied inan array of novel formats principally for examining thepe-
ripheral skeleton. Quantitative computed tomography (QCT) was extensively
investigated both for central and peripheral (pQCT) skeletal imaging. The
early isotope-based pQCT systems were converted to X-ray based systems in
the late 80s’. Similarly, during this period, the SPA technique was advanced
to dual photon absorptiometry (DPA), permitting quantitative imaging of the
central skeleton, mainly the spine and hip. At the same time pharmaceutical
interest expanded in the area of osteoporosis therapeutics with exploration of
a variety of estrogen and HRT regimens and the development of first and later
generation bisphosphonates. Dual-X-ray absorptiometry (DXA) represented a
major technological advance, replacing isotope-based DPA, and improving
the speed, precision and spatial resolution, thus thrusting it from mostly clin-
ical trial application into broad routine clinical practice.
During the most recent 20 years, the DXA technology has further advanced
from pencil-beam, single-detector to fan-beam multi-detector array,
further improving performance and the breadth of applications. These
have included analysis of body composition, hip structure analysis (HSA),
quasi 3-dimensional rendering (VXA), higher resolution imaging with verte-
bral fracture assessment (VFA), detection of atypical femoral fractures (AFF)
and assessment of aortic calcification. Similarly, CT technology has evolved
dramatically, to a high-resolution, fan-beam, multi-detector, spiral-scanning
mode, greatly enhancing speed, coverage and efficiency. These CT de-
velopments have enabled broader clinical research applications with true 3-
D acquisition and analysis (vQCT), high resolution operation (hrCT) for
assessing central skeletal structure and compartments. Special purpose
advanced Micro CT (mCT) systems have also been developed, these for
imaging small animals and bone specimens, or for in vivo human imaging of
the “micro” structure of the distal radius and tibia. Simultaneously over this
time, MRI technology has continued its remarkable evolution, through many
configurations, becoming today, the most diverse and powerful of medical
imaging systems. Both magnetic resonance imaging and spectroscopy have
contributed to the examination of macro and micro skeletal structure as
well as to compositional changes in the bone marrow lipid and water compo-
nents. For both MRI and CT, the equipment and hardware advances have
been accompanied by impressive developments in computer sciences and
image processing, which have facilitated applications for analysis of skeletal
macro- and micro-structure, extending well beyond simple BMD measures.
Biomechanically relevant skeletal information has been derived using these
advanced computational capabilities, based upon CT- or mCT-derived data,
and applying the principles of finite element analysis (FEA and mFEA). The
FEA approaches have been focused especially on estimating the structural
integrity of the spine and femur in vivo in humans, and mFEA to exploringgapore) Pte Ltd. This is an open access article under the CCBY-NC-ND
188 Abstractsthe mechanisms and consequences of bone fragility in vitro in specimens and
in vivo in laboratory animals.
Now, for this 20th IBDW, we have assembled senior scientists and clinicians,
along with post-doctoral students and trainees, to observe and deliver an
amazing array of presentations covering traditional and more novel de-
velopments and applications of CT, MRI and ultrasound imaging and
quantification. We address not only morphological imaging but also func-
tional, cellular and molecular imaging. We explore not only technical
developments related to imaging the osseous tissues but also to imaging
and quantifying muscular, cartilaginous, vascular and hematopoietic tissues
across a range of disorders.
In summary, the past four decades have witnessed tremendous progress in
the development and application of quantitative bone and soft tissue
imaging techniques. These currently provide a vast array of exquisite
research and clinical tools to examine and explore the depths and
boundaries of human and animal tissues in health and disease. Over this
time interval, The International Bone Density Workshop series, and its
leaders, participants and sponsors have been instrumental, indeed pivotal,
in promoting and fostering the development, advancement and maturation
of these most exciting research arenas.Table. International bone density workshops e presidents, locations and
years.
Presidents Conference Locations Year
1 Harry K. Genant San Francisco, California,
USA
1979
2 Peter Ruegsegger Zuoz, Switzerland 1981
3 Thomas R. Overton &
Thomas N. Hangartner
Banff, Canada 1982
4 Anne-Marie Laval-Jeantet Fontevraud, France 1984
5 Frederick S. Kaplan Bretton Woods,
New Hampshire, USA
1985
6 Judith E. Adams Buxton, England 1987
7 Bruce Ettinger Rancho Mirage,
California, USA
1989
8 Dieter Felsenberg &
Willi Kalender
Bad Reichenhall, Germany 1991
9 Dianna D. Cody &
Bradford J. Richmond
Traverse City, Michigan, USA 1992
10 Sergio Ortolani &
Maria Luisa Bianchi
Venice, Italy 1994
11 Kenneth G. Faulkner &
Michael R. McClung
Gleneden Beach, Oregon, USA 1995
12 David Reid & Peter Tothill Crieff, Scotland 1997
13 Charles R. Wilson Delavan, USA 1998
14 Claus Glueer Warnemuende, Germany 2000
15 Sharmila Majumdar &
John Shepherd
Monterey, California, USA 2002
16 Didier Hans & Pascal Laugier Annecy, France 2004
17 Akira Itabashi, Masako Ito &
Masao Fukunaga
Kyoto, Japan 2006
18 Giuseppe Guglielmi Pugnochiuso, Italy 2008
19 Paul D. Miller Breckenridge, Colorado, USA 2012
20 Ling Qin & James F. Griffith Hong Kong 2014Brief CV
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Second only to cardiovascular disease in producing long term disability[1],
osteoarthritis (OA) is a chronic degenerative disease in which the salient
feature is the progressive loss of articular cartilage. Traditionally, OA has
been diagnosed via radiographic examination, which relies on the assess-
ment of secondary indicators of disease such as the presence or absence of
osteophytes and the width of the joint space for diagnosis [2,3]. However,
this approach is limited in that it is effective only at later stages of disease
progression because soft tissue quality can only be inferred from relative
bone appearance and health using planar X-ray imaging techniques [4].
Moreover, in OA the early stages of cartilage degeneration are often marked
by the loss of specific biologic components of the cartilage matrix [5e8]:
changes that are invisible in conventional radiographs.
Magnetic resonance imaging (MRI) has been used to assess cartilage
morphology directly and has shown promise for the detection of soft tissue
changes 4, 9e12. In particular, T2 and T1r relaxation times have proven to
be valuable in the assessment of cartilage biochemistry, in particular
hydration, proteoglycan and collagen content, and collagen orientation
[9e15]. T2 tissue relaxation time has been found to be inversely correlated
with both cartilage volume and thickness, and focal areas of increased T2
